You are viewing the site in preview mode
Skip to main content
| |
Total N = 1422
|
ECD n = 325
|
Non-ECD n = 1097
|
p value
|
|---|
|
Age at transplant, years
| | | | |
|
Mean (SD)
|
54 (13)
|
59 (11)
|
53 (13)
|
<0.001
|
|
Women
|
503 (35 %)
|
105 (32 %)
|
398 (36 %)
|
0.188
|
|
Race
| | | | |
|
Caucasian (%)
|
884 (62 %)
|
197 (61 %)
|
687 (63 %)
|
0.777
|
|
Asian (%)
|
121 (9 %)
|
32 (10 %)
|
89 (8 %)
|
|
African-American (%)
|
127 (9 %)
|
31 (10 %)
|
96 (9 %)
|
|
Aboriginal (%)
|
36 (3 %)
|
6 (2 %)
|
30 (3 %)
|
|
Other (%)
|
236 (17 %)
|
56 (17 %)
|
180 (16 %)
|
|
Unknown
|
18
|
–
|
–
| |
|
Primary cause of ESRD
| | | | |
|
Glomerulonephritis (%)
|
328 (29 %)
|
68 (26 %)
|
260 (31 %)
|
0.010
|
|
Diabetes mellitus (%)
|
215 (19 %)
|
66 (25 %)
|
149 (18 %)
|
|
Hypertension (%)
|
95 (9 %)
|
30 (11 %)
|
65 (8 %)
|
|
Other (%)
|
474 (43 %)
|
97 (37 %)
|
377 (44 %)
|
|
Unknown
|
310
|
–
|
–
| |
|
Pre-transplant dialysis time (months)
| | | | |
|
Median (Q1–Q3)
|
58 (34-85)
|
54 (36–76)
|
59 (33–86)
|
0.075
|
|
Peak PRA >0 % (%)
|
792 (56 %)
|
186 (57 %)
|
606 (55 %)
|
0.134
|
|
Missing
|
122
|
–
|
–
| |
|
Re-graft (%)a
|
96 (7 %)
|
8 (2 %)
|
88 (8 %)
|
<0.001
|
|
Comorbidities
| | | | |
|
Diabetes mellitus (%)
|
491 (35 %)
|
144 (44 %)
|
347 (32 %)
|
<0.001
|
|
Hypertension (%)
|
1334 (94 %)
|
310 (95 %)
|
1024 (93 %)
|
0.198
|
|
Cardiovascular disease (%)
|
117 (8 %)
|
36 (11 %)
|
81 (7 %)
|
0.033
|
|
Mean Charlson comorbidity index (SD)b
|
2.6 (1.4)
|
2.7 (1.5)
|
2.5 (1.4)
|
0.03
|
- Reported values in percent are based on a denominator excluding unknown values.
-
aRecipients of failed living donor kidney transplants now receiving first time deceased kidney transplant.
-
bThe Charlson score is a validated index of comorbidity [33].
-
ESRD end-stage renal disease, PRA panel reactive antibody
